B HALL STRATEGIES, LLC

Lobbying for TIBER CREEK GROUP ON BEHALF OF JAZZ PHARMACEUTICALS · Biopharmaceutical company.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · Senate · $30,000.00 income · posted Jul 21, 2025

Lobbying activity 1

Medicare/Medicaid

Issues related to Orphan drug coverage under Medicare.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.